Global DNA Methylation Sequencing Market Research Report 2024

DNA methylation is an important component of epigenetics and plays an important role in maintaining normal cell function, genetic imprinting, embryonic development, and human tumorigenesis. Whole Genome Bisulfite Sequencing (WGBS), which treats genomic DNA with bisulfite to convert unmethylated cytosine C to uracil U, and performs whole-genome weighting on the treated DNA Sequencing and comparison with the reference genome to achieve single-base resolution and high-accuracy methylation level analysis from the genome level, widely used in basic mechanisms such as cell differentiation, tissue development, animal and plant breeding, human health And research fields such as disease treatment.

The global DNA Methylation Sequencing market was valued at US$ 1208 million in 2023 and is anticipated to reach US$ 3532 million by 2030, witnessing a CAGR of 16.9% during the forecast period 2024-2030.

DNA methylation sequencing is a technique used in genomics and epigenetics research to analyze DNA methylation patterns, which play a crucial role in gene regulation and various biological processes. This market has witnessed significant growth due to its relevance in understanding disease mechanisms, identifying biomarkers, and advancing personalized medicine. Continuous developments in DNA methylation sequencing technologies, such as bisulfite sequencing, whole-genome bisulfite sequencing (WGBS), and targeted methylation sequencing, have improved accuracy and reduced costs. The emergence of single-cell DNA methylation sequencing techniques has enabled the study of methylation patterns at the single-cell level, opening up new research possibilities.

This report aims to provide a comprehensive presentation of the global market for DNA Methylation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Methylation Sequencing.

Report Scope

The DNA Methylation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Methylation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DNA Methylation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Berry Genomics

Illumina Inc.

Diagenode

Novogene

Qiagen N.V.

Oebiotech

Biomarker

Sigma Aldrich Corporation

BGI

F. Hoffmann-La Roche Ltd.

Zymo Research Corporation

Illumina

Thermo Fisher Scientific

Oxford Nanopore Technologies

PacBio (Pacific Biosciences)

Qiagen

Zymo Research

Agilent Technologies

BGI (Beijing Genomics Institute)

EpigenDx

BaseClear


Segment by Type


Whole Genome Bisulfite Sequencing (WGBS)

Reduced Representation Bisulfite Sequencing (RRBS)

MeDIP-Sequncing


Segment by Application


Epigenetic Research

Massive Clinical Sample Studies

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DNA Methylation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Frequently Asked Questions